GUILLERMO
LÓPEZ VIVANCO
Ikertzailea 2022-(e)ra arte
Complexo Hospitalario Universitario de Santiago
Santiago de Compostela, EspañaComplexo Hospitalario Universitario de Santiago-ko ikertzaileekin lankidetzan egindako argitalpenak (3)
2021
-
First-line osimertinib in patients with epidermal growth factor receptor–mutant non–small-cell lung cancer and with a coexisting low allelic fraction of Thr790Met
European Journal of Cancer, Vol. 159, pp. 174-181
2016
-
Nab-Paclitaxel in metastatic breast cancer: Defining the best patient profile
Current Cancer Drug Targets, Vol. 16, Núm. 5, pp. 415-428
-
Treatment patterns of adjuvant interferon-α2b for high-risk melanoma: A retrospective study of the Grupo Español Multidisciplinar de Melanoma - Prima study
Melanoma Research, Vol. 26, Núm. 3, pp. 278-283